Projects
This section presents pharmaceutical projects that are announced from time-to-time around the world.
AbbVie to Invest US$380 Million in North Chicago, USA
AbbVie has announced an investment of US$380 million to construct two active pharmaceutical ingredient API manufacturing facilities at its North Chicago campus in Illinois, USA
Vetter Pharma to Invest US$530 million (€480 Million) in Saarlouis, Germany
Vetter Pharma has announced plans to invest approximately US$530 million 480 million in the first phase of a new commercial manufacturing facility in Saarlouis, Germany
Novo Nordisk to Invest over US$467 Million (€400 Million) in Athlone, Ireland
Novo Nordisk has announced plans to invest over US$467 million 400 million to expand its tablet manufacturing facility in Athlone, Ireland
Johnson & Johnson to Invest over US$1 Billion in Pennsylvania, USA
Johnson Johnson has announced an investment of over US$1 billion to develop a nextgeneration cell therapy manufacturing facility in Montgomery County, Pennsylvania, USA The development will support the production of advanced cell therapies used in the treatment of cancer
FUJIFILM Biotechnologies to Invest US$500 Million (£400 Million) in Teesside, United Kingdom
FUJIFILM Biotechnologies has announced an investment of approximately US$500 million 400 million to expand its biomanufacturing and process development facilities in Teesside, United Kingdom The development involves the expansion of biomanufacturing and process development facilities to support
Eli Lilly to Invest over US$3.5 Billion in Pennsylvania, USA
Eli Lilly and Company has announced plans to invest more than US$35 billion in a new injectable medicine and device manufacturing facility in Lehigh Valley, Pennsylvania, USA The development involves the construction of an injectable medicine and device manufacturing facility to support
Axplora to Invest US$35 Million (€30 Million) in Le Mans, France
Axplora has announced a US$35 million 30 million investment to expand lyophilisation capabilities at its facility in Le Mans, France The development involves the expansion of lyophilisation capacity at an existing pharmaceutical manufacturing facility, supporting the freezedrying of materials
BD to Expand its Manufacturing Site in Columbus, USA
BD Becton, Dickinson and Company has announced plans to invest US$110 million to expand production of prefillable syringes at its manufacturing site in Columbus
Novartis to Invest US$23 Billion in Florida, USA
Novartis has announced plans to invest US$23 billion to build a radioligand therapy manufacturing facility in Winter Park
Genentech to Invest US$2 Billion in North Carolina, USA
Genentech has announced plans to invest approximately US$2 billion to expand its manufacturing facility in Holly Springs, North Carolina, USA
